Pilot and Feasibility Program
Pilot and Feasibility Program
批准号:
10163170
负责人:
MATTHEW H WILSON
金额:
$19.94万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-08 至 2023-06-30
关键词:
AppointmentArizonaEligibility DeterminationFacultyFundingGoalsGrantGuidelinesInstitutionKidneyKidney DiseasesMinorityModelingPilot ProjectsReagentResearchResearch PersonnelResearch Project GrantsResearch SupportTimeUnited States National Institutes of HealthUniversitiesUtahWashingtoninnovationinstructorinterestmembermouse modelnephrogenesisnovelprogramsranpirnasetool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
The pilot and feasibility (P&F) grant program represents an extremely valuable and effective opportunity for the
Vanderbilt O'Brien Kidney Center to provide funds for the support of kidney disease related projects. Funding
for the P&F program started in 2002 during a previous funding cycle for the O'Brien centers (2002-2007) and
continued through the P30 Vanderbilt O'Brien Kidney Center (2008-2013). For this competitive application, the
goal of the program continues to be to support i) small research projects by new investigators with little or no
independent research support; ii) established investigators who are turning to kidney-related research for the
first time; or iii) established investigators in kidney related research who are undertaking a strikingly new
research direction. Applicants must hold a faculty appointment (Instructor or above) to submit a P&F proposal,
and must meet the NIH Eligibility Guidelines for P&F support. In our previous funding cycles (2002-2013), the
Vanderbilt O'Brien Kidney Center funded 19 applications, from a total of 53 applications. Summaries of the
funded applications are detailed below. For this application, we are requesting funding for 9 applications for
years 2017-2022, all of which will meet the guidelines of our P&F program and will extensively utilize our
proposed biomedical cores.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Next generation transposon vectors for genome engineering
-
批准号:10688194
-
项目类别:
-
资助金额:$49.15万
-
财政年份:2022
-
负责人:MATTHEW H WILSON
-
依托单位:
Next generation transposon vectors for genome engineering
-
批准号:10501335
-
项目类别:
-
资助金额:$52.55万
-
财政年份:2022
-
负责人:MATTHEW H WILSON
-
依托单位:
Metabolic consequences of cystinuria and genome engineering therapeutics
-
批准号:10265368
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:MATTHEW H WILSON
-
依托单位:
Genome engineering therapeutics for cystinuria and its metabolic consequences.
-
批准号:10588590
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:MATTHEW H WILSON
-
依托单位:
Metabolic consequences of cystinuria and genome engineering therapeutics
-
批准号:9898319
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:MATTHEW H WILSON
-
依托单位:
Kidney specific site-directed integration for cystinuria
-
批准号:8542365
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:MATTHEW H WILSON
-
依托单位:
Novel cell therapy for anemia of CKD
-
批准号:8305209
-
项目类别:
-
资助金额:$34.04万
-
财政年份:2012
-
负责人:MATTHEW H WILSON
-
依托单位:
Novel cell therapy for anemia of CKD
-
批准号:8708060
-
项目类别:
-
资助金额:$34.15万
-
财政年份:2012
-
负责人:MATTHEW H WILSON
-
依托单位:
Novel cell therapy for sustained therapeutic protein delivery in vivo
-
批准号:10428544
-
项目类别:
-
资助金额:$41.67万
-
财政年份:2012
-
负责人:MATTHEW H WILSON
-
依托单位:
Novel cell therapy for sustained therapeutic protein delivery in vivo
-
批准号:10011826
-
项目类别:
-
资助金额:$41.67万
-
财政年份:2012
-
负责人:MATTHEW H WILSON
-
依托单位:
Novel cell therapy for anemia of CKD
-
批准号:8786955
-
项目类别:
-
资助金额:$32.72万
-
财政年份:2012
-
负责人:MATTHEW H WILSON
-
依托单位:
Novel cell therapy for anemia of CKD
-
批准号:8467713
-
项目类别:
-
资助金额:$0.13万
-
财政年份:2012
-
负责人:MATTHEW H WILSON
-
依托单位:
Novel cell therapy for sustained therapeutic protein delivery in vivo
-
批准号:10190918
-
项目类别:
-
资助金额:$41.67万
-
财政年份:2012
-
负责人:MATTHEW H WILSON
-
依托单位:
海外基金